|
TIAM2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.012000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.281200E-03 |
| Normal-vs-Stage2 |
9.582400E-02 |
| Normal-vs-Stage3 |
3.225600E-01 |
| Normal-vs-Stage4 |
7.345000E-01 |
| Stage1-vs-Stage2 |
8.287000E-01 |
| Stage1-vs-Stage3 |
4.101800E-01 |
| Stage1-vs-Stage4 |
6.832200E-01 |
| Stage2-vs-Stage3 |
6.236200E-01 |
| Stage2-vs-Stage4 |
7.693600E-01 |
| Stage3-vs-Stage4 |
9.540000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.927900E-02 |
| Normal-vs-AfricanAmerican |
1.455560E-01 |
| Normal-vs-Asian |
1.828140E-02 |
| Caucasian-vs-AfricanAmerican |
8.860800E-01 |
| Caucasian-vs-Asian |
4.114800E-01 |
| AfricanAmerican-vs-Asian |
4.201200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.355700E-02 |
| Normal-vs-Female |
1.902180E-01 |
| Male-vs-Female |
8.338000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.647900E-02 |
| Normal-vs-Extreme_Weight |
9.957000E-04 |
| Normal-vs-Obese |
3.235000E-01 |
| Normal-vs-Extreme_Obese |
9.258500E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.702000E-01 |
| Normal_Weight-vs-Obese |
3.450200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.490600E-01 |
| Extreme_Weight-vs-Obese |
2.765600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.116400E-01 |
| Obese-vs-Extreme_Obese |
3.688600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.872400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.440400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.179800E-03 |
| Normal-vs-Age(81-100Yrs) |
2.504300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.101800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.983600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.671970E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.081990E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.881800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.056200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.444400E-01 |
| Normal-VS-Type2 PRCC |
1.565840E-04 |
| Normal-VS-KIRP CIMP |
3.103900E-03 |
| Normal-VS-Unclassified PRCC |
7.830800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.616850E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.286640E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.751200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.398000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.717700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.758400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.094000E-01 |
| Normal-vs-N1 |
7.337000E-01 |
| Normal-vs-N2 |
1.398520E-03 |
| N0-vs-N1 |
2.737600E-01 |
| N0-vs-N2 |
1.993910E-02 |
| N1-vs-N2 |
3.757100E-03 |
|
|
